Talwar Shivangi, Sood Shivani, Kumar Jayant, Chauhan Ritu, Sharma Mamta, Tuli Hardeep Singh
Amity Institute of Biotechnology, Amity University, Noida, Noida, India.
Department of Biotechnology, Mukand Lal National College, Yamuna Nagar, India.
Curr Pharmacol Rep. 2020;6(6):354-363. doi: 10.1007/s40495-020-00245-2. Epub 2020 Oct 22.
In the last month of 2019, i.e., December, COVID-19 hit Wuhan city in China. Since then, it has infected more than 210 countries and nearly about 33.4 million people with one million deaths globally. It is a viral disease with flu-like symptoms; hence, prevention and management is the best option to be adopted for its cure.
Many healthcare systems, scientists, and researchers are fighting for the cure of this pandemic. Ayurvedic and allopathic treatments have been studied extensively and approached for the cure of COVID-19. In addition to ayurvedic treatments, the Ministry of Ayush, India, has also recommended many remedies to boost up immunity. Allopathic studies involved several antiviral drugs which were used in different combinations for the treatment of COVID-19.
Comparative analysis of Ayurveda and allopathic treatment strategies were carried out in the present study. Depending upon the patient's conditions and symptoms, Ayurveda is useful for the treatment of COVID-19. Allopathic treatments inhibit viral infection by targeting majorly endocytosis, and angiotensin-converting enzyme (Ace) receptor signaling. In this article, we summarize different ayurvedic and allopathic medicines and treatment strategies which have been used for the treatment of COVID-19, a global pandemic.
2019年的最后一个月，即12月，新型冠状病毒肺炎在中国武汉市爆发。从那时起，它已感染了210多个国家，全球近3340万人感染，100万人死亡。这是一种具有流感样症状的病毒性疾病；因此，预防和管理是治疗该病的最佳选择。
许多医疗系统、科学家和研究人员都在为治愈这一流行病而努力。阿育吠陀医学和对抗疗法都已被广泛研究并用于治疗新型冠状病毒肺炎。除了阿育吠陀疗法外，印度阿育吠陀部还推荐了许多增强免疫力的疗法。对抗疗法研究涉及几种抗病毒药物，这些药物以不同组合用于治疗新型冠状病毒肺炎。
本研究对阿育吠陀医学和对抗疗法的治疗策略进行了比较分析。根据患者的病情和症状，阿育吠陀医学对治疗新型冠状病毒肺炎有用。对抗疗法主要通过靶向内吞作用和血管紧张素转换酶（Ace）受体信号传导来抑制病毒感染。在本文中，我们总结了用于治疗全球大流行疾病新型冠状病毒肺炎的不同阿育吠陀医学和对抗疗法药物及治疗策略。
